A

228P Modelling T cell-vasculature interaction in a high-throughput microfluidic platform

Immuno-Oncology Technology, vol. 16, pp. 100339

Abstract

Recent clinical success of immune checkpoint inhibitors and chimeric antigen receptor T cells has highly increased the attention for the field of immunotherapy. However, identifying responders to these therapies is challenging underscoring the necessity for translational models that increase understanding of tumor-immune responses.

Authors 6

  1. Mimetas (Netherlands)

    Affiliation as printed

    Mimetas, Oegstgeest, Netherlands

  2. Mimetas (Netherlands)

    Affiliation as printed

    Mimetas, Oegstgeest, Netherlands

  3. H. Lanz Aachen Mimetas

    Mimetas (Netherlands)

    Affiliation as printed

    Mimetas, Oegstgeest, Netherlands

  4. J. Joore Aachen Mimetas

    Mimetas (Netherlands)

    Affiliation as printed

    Mimetas, Oegstgeest, Netherlands

  5. Mimetas (Netherlands)

    Affiliation as printed

    Mimetas, Oegstgeest, Netherlands

  6. Mimetas (Netherlands)

    Affiliation as printed

    Mimetas, Oegstgeest, Netherlands

Cited by 0 stored of 0

No patents citing this paper on Lens.org (checked 2026-10-11).

References 0